Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2904
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00254293 | Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA) | ||
| NCT05811416 | A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants | ||
| NCT02599649 | Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS) | ||
| NCT00665444 | Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder | ||
| NCT03426618 | A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Chronic Hepatitis B | ||
| NCT00135382 | Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen | ||
| NCT01848028 | PsoBest - The German Psoriasis Registry | ||
| NCT02305563 | An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia | ||
| NCT00135447 | A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen | ||
| NCT06499298 | Retrospective Evaluation of Nivolumab in Adjuvant Esophageal Cancer/Gastroesophageal Junction Cancer | ||
| NCT00559247 | A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects | ||
| NCT03568435 | Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants | ||
| NCT04396821 | A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors | ||
| NCT05470985 | A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy | ||
| NCT02628340 | Comprehensive Analysis of HIV Reservoirs in Chronically Infected HIV-1 Treated Patients | ||
| NCT06422247 | Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy | ||
| NCT01409174 | IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma | ||
| NCT00000781 | A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3) | ||
| NCT05620407 | A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus | ||
| NCT00388557 | Effect of Ketoconazole on the Pharmacokinetics of Vinflunine | ||
| NCT04209699 | A Study Comparing the Effects of Famotidine Pretreatment and of Food on the Relative Bioavailability of BMS-986165 in Healthy Volunteers | ||
| NCT05369832 | An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice | ||
| NCT01716806 | A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) | ||
| NCT01658878 | An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer | ||
| NCT03674476 | An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function | ||
| NCT01708889 | Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction | ||
| NCT02575222 | Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma | ||
| NCT03721757 | CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer | ||
| NCT00847782 | An Experimental Medicine Study to Evaluate Serum Biomarkers of Lipid Metabolism | ||
| NCT01082562 | Safety Study of BMS-844421 for Treatment of Hypercholesterolemia | ||
| NCT01793103 | Brigham and Women's Rheumatoid Arthritis Sequential Study | ||
| NCT07091695 | Real-world Outcomes Among Patients With Melanoma Treated With Neoadjuvant Nivolumab+Relatlimab or Nivolumab+Ipilimumab | ||
| NCT05048212 | A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases | ||
| NCT02713867 | A Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks | ||
| NCT00928031 | Long-term Data Collection for Subjects in MDX-010 Studies | ||
| NCT03038711 | A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers | ||
| NCT00000671 | A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment | ||
| NCT03158272 | A Study of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread | ||
| NCT05997277 | Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS). | ||
| NCT02103569 | Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325 | ||
| NCT02211469 | A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986104 in Healthy Male Subjects | ||
| NCT00337805 | Double Blind Randomized Trial of Saline vs Pentaspan for Resuscitation After Cardiac Surgery | ||
| NCT02706405 | JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma | ||
| NCT05432622 | A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy | ||
| NCT01354431 | BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC) | ||
| NCT04204837 | Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin | ||
| NCT03804554 | A Study of Participants in Australia Who Have Non-small Cell Lung Cancer Being Treated With Nivolumab | ||
| NCT02011945 | A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia | ||
| NCT03502330 | APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma | ||
| NCT05077956 | Sema 4A as a Marker for Inflammatory Disease in Multiple Sclerosis |
